Vimarsana
Biggest News Aggregation in the World

Page 5 - Lobe Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lobe Sciences Today - Breaking & Trending Today

The Power Play by The Market Herald Releases New Interviews with ARway, ... - Vimarsana News

The Power Play by The Market Herald Releases New Interviews with ARway, ...

The Power Play by The Market Herald Releases New Interviews with ARway, ...

Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC - Vimarsana News

Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC

Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and

Lobe Sciences Ltd.: Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance - Vimarsana News

Lobe Sciences Ltd.: Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance

Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering

Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry - Vimarsana News

Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry

/PRNewswire/ -- Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of...

Lobe Sciences Limited inks clinical research agreement with Integrative Headache Medicine of New York to study L-130 as chronic cluster headache treatment - Vimarsana News

Lobe Sciences Limited inks clinical research agreement with Integrative Headache Medicine of New York to study L-130 as chronic cluster headache treatment

Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED), which is focused on developing psychedelic-derived medicines for neurologic disease, revealed that it has signed...